Abstract
The purpose of this phase II trial was to investigate the efficacy and safety of a combination chemotherapy with gemcitabine, vinorelbine and cisplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC). Patients with NSCLC stage IIIB or IV disease received 1000 mg/m(2) gemcitabine and 25 mg/m(2) vinorelbine on days 1 and 8 and 75 mg/m(2) cisplatin on day 2, every 3 weeks. From December 1998 to May 1999, 31 patients (21 stage IV and 10 stage IIIB disease), with a median age of 59 years (range 40-72 years) were enrolled. The overall intent-to-treat response rate was 45% (95% confidence interval (CI): 27-64%) with 2 complete responders (CR) and 12 partial responders (PR), 7 patients had stable disease and 10 progressed. Median survival was 12.8 months (95% CI: 6.5-12.8+ months), median time to progression was 5.1 months (95% CI: 3.5-7.7 months), and the 1-year survival rate was 52.9% (95% CI: 36.7-76.2%). Patients with stage IIIB disease had a significantly longer overall survival than patients with stage IV disease (P=0.05). Transient World Health Organization (WHO) grade IV leucopenia, anaemia and thrombocytopenia occurred in 3 (10%), 2 (6%) and 3 (10%) patients, respectively. The predominant non-haemato...Continue Reading
References
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P BerthaudT Tursz
Oct 1, 1991·American Journal of Clinical Oncology·G L WamplerJ A Phillips
Oct 7, 1995·BMJ : British Medical Journal
Dec 1, 1994·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·K FuruseA Sakuma
Aug 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R P AbrattT A Rugg
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H AndersonH H Hansen
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T Le ChevalierS Cigolari
Jun 1, 1993·Cancer·B JeremicS Milisavljevic
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R GrilliJ A Julian
Jan 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I Cojean, T Le Chevalier
Feb 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U GatzemeierM Voi
Mar 1, 1996·Cancer Treatment Reviews·S A JohnsonP Pouillart
Jan 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ThatcherH Anderson
Jun 13, 1998·Anti-cancer Drugs·M S AaproS Hatty
Feb 20, 1999·American Journal of Clinical Oncology·F RecchiaS Rea
Apr 1, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·P GinopoulosA Mastorakou
Nov 24, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·W W ten Bokkel HuininkC Manegold
Nov 26, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B SørensenH H Hansen
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F RecchiaS Rea
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·C BoniV Pajetta
Apr 6, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E LaackD K Hossfeld
Apr 19, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M MauerE E Vokes
Jan 22, 2004·Clinical Lung Cancer·P ComellaUNKNOWN Southern Italy Cooperative Oncology Group Study
Apr 11, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R BootonN Thatcher
Oct 31, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P ComellaUNKNOWN Southern Italy Cooperative Oncology Group
Nov 3, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y OheM Fukuoka
Citations
Jul 22, 2005·Investigational New Drugs·Emilio Esteban-GonzalezAngel J Lacave
Jan 4, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Y M ChenC M Tsai
Oct 27, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J MontalarA Segura
Dec 12, 2001·Critical Reviews in Oncology/hematology·M S AaproJ B Vermorken
Nov 26, 2005·Cancer Chemotherapy and Pharmacology·Javier Castro de CarpeñoUNKNOWN Oncopaz Cooperative Group (Spain)
Jul 19, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J TrédanielS Culine
Feb 17, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yuh-Min ChenJacqueline Whang-Peng
Apr 9, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jeong-A ParkThad T Ghim
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V AlberolaUNKNOWN Spanish Lung Cancer Group